Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc.verified

EMMA

Price:

$0.0129

Market Cap:

$823.87K

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. Emmaus ...[Read more]

Industry

Biotechnology

IPO Date

2000-05-09

Stock Exchange

OTC

Ticker

EMMA

The Enterprise Value as of December 2025 (TTM) for Emmaus Life Sciences, Inc. (EMMA) is 32.22M

According to Emmaus Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.22M. This represents a change of -0.32% compared to the average of 32.32M of the last 4 quarters.

Emmaus Life Sciences, Inc. (EMMA) Historical Enterprise Value (quarterly & annually)

How has EMMA Enterprise Value performed in the past?

The mean historical Enterprise Value of Emmaus Life Sciences, Inc. over the last ten years is 46.69M. The current 32.22M Enterprise Value has changed 6.80% with respect to the historical average. Over the past ten years (40 quarters), EMMA's Enterprise Value was at its highest in in the September 2019 quarter at 120.63M. The Enterprise Value was at its lowest in in the September 2016 quarter at 2.99M.

Quarterly (TTM)
Annual

Average

46.69M

Median

38.54M

Minimum

3.63M

Maximum

109.89M

Emmaus Life Sciences, Inc. (EMMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Emmaus Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 318.83%

Maximum Annual Enterprise Value = 109.89M

Minimum Annual Increase = -62.62%

Minimum Annual Enterprise Value = 3.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202432.11M-9.34%
202335.42M-15.00%
202241.67M-62.08%
2021109.89M43.38%
202076.64M-24.08%
2019100.96M115.05%
201846.94M318.83%
201711.21M209.08%
20163.63M-57.06%
20158.44M-62.62%

Emmaus Life Sciences, Inc. (EMMA) Average Enterprise Value

How has EMMA Enterprise Value performed in the past?

The current Enterprise Value of Emmaus Life Sciences, Inc. (EMMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

36.40M

5-year avg

59.15M

10-year avg

46.69M

Emmaus Life Sciences, Inc. (EMMA) Enterprise Value vs. Peers

How is EMMA’s Enterprise Value compared to its peers?

Emmaus Life Sciences, Inc.’s Enterprise Value is greater than SQZ Biotechnologies Company (-35353266.00), greater than Orgenesis Inc. (20.97M), greater than Bio-Path Holdings, Inc. (1.09M), greater than Yulong Eco-Materials Limited (2.09M), greater than NeutriSci International Inc. (895.48K), greater than Viropro Inc. (142.03K), greater than Pure Harvest Corporate Group, Inc. (2.15M), greater than Helix BioMedix, Inc. (-1240640.00), greater than Vibe Growth Corporation (2.03M), greater than Nutra Pharma Corp. (12.10M),

Build a custom stock screener for Emmaus Life Sciences, Inc. (EMMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emmaus Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emmaus Life Sciences, Inc. (EMMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emmaus Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Emmaus Life Sciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Emmaus Life Sciences, Inc. (EMMA)?

What is the 3-year average Enterprise Value for Emmaus Life Sciences, Inc. (EMMA)?

What is the 5-year average Enterprise Value for Emmaus Life Sciences, Inc. (EMMA)?

How does the current Enterprise Value for Emmaus Life Sciences, Inc. (EMMA) compare to its historical average?